Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Interleukin-1β Inhibits γ-Aminobutyric Acid Type A (GABAA) Receptor Current in Cultured Hippocampal Neurons

Sam Wang, Qing Cheng, Sundeep Malik and Jay Yang
Journal of Pharmacology and Experimental Therapeutics February 2000, 292 (2) 497-504;
Sam Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qing Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sundeep Malik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Interleukin-1β (IL-1β), a polypeptide immune mediator, is induced within the central nervous system in response to a variety of pathological stimuli, including systemic infection, hypoxia, brain trauma, and seizure. IL-1β action on the γ-aminobutyric acid type A (GABAA) inhibitory neurotransmitter receptor was investigated in whole cell patch-clamped cultured hippocampal neurons. Application of IL-1β at concentrations encountered in pathophysiological conditions (1–10 ng/ml; 59–590 pM) irreversibly decreased the peak magnitude of current elicited by 30 μM GABA. Current inhibition was IL-1β concentration- and time-dependent and was prevented by a specific IL-1β type I receptor antagonist. No significant changes in current kinetics or reversal potential were observed. The IL-1β depression of GABA current was inhibited by high concentrations of nonspecific kinase inhibitors staurosporine (500 nM) and 1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine (H-7; 50 μM), but not by a protein kinase C selective inhibitor calphostin C (5 μM). We conclude that IL-1β inhibits GABAA receptor function in hippocampal neurons by the involvement of an unidentified kinase. This blockade of the GABAA inhibitory neurotransmitter receptor may underlie the central nervous system hyperexcitability seen in many pathophysiological conditions.

Footnotes

  • Send reprint requests to: Dr. Jay Yang, Department of Anesthesiology, Box 604, University of Rochester Medical Center, 601 Elmwood Ave., Rochester, NY 14642. E-mail: jyang{at}anes.rochester.edu

  • 1 This work was supported by National Institutes of Health Grants GM52325 (to J.Y.) and T32-DA07232 (to S.M.).

  • Abbreviations:
    IL-1β
    interleukin-1β
    IL-1RI
    interleukin-1 type I receptor
    IL-1Ra
    interleukin-1 receptor antagonist
    Erev
    reversal potential
    GABA
    γ-aminobutyric acid
    GABAA
    γ-aminobutyric acid type A
    PKA
    cAMP-dependent protein kinase
    PKC
    protein kinase C
    β-PMA
    β-phorbol 12-myristate 13-acetate
    H-7
    1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine
    PBST
    PBS with 0.2% Tween 20
    NGS
    normal goat serum
    • Received August 9, 1999.
    • Accepted October 12, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 292 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 292, Issue 2
1 Feb 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interleukin-1β Inhibits γ-Aminobutyric Acid Type A (GABAA) Receptor Current in Cultured Hippocampal Neurons
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Interleukin-1β Inhibits γ-Aminobutyric Acid Type A (GABAA) Receptor Current in Cultured Hippocampal Neurons

Sam Wang, Qing Cheng, Sundeep Malik and Jay Yang
Journal of Pharmacology and Experimental Therapeutics February 1, 2000, 292 (2) 497-504;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNEUROPHARMACOLOGY

Interleukin-1β Inhibits γ-Aminobutyric Acid Type A (GABAA) Receptor Current in Cultured Hippocampal Neurons

Sam Wang, Qing Cheng, Sundeep Malik and Jay Yang
Journal of Pharmacology and Experimental Therapeutics February 1, 2000, 292 (2) 497-504;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Oxysterols and ethanol
  • P-glycoprotein Apical Efflux Ratio for Compound Optimization
  • Pharmacology of Carbamate Insecticides at MT1 & MT2
Show more Neuropharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics